(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
IDF destroys two-kilometer-long Gaza terror tunnel in Beit Lahiya - 2A Manual for Nations with Extraordinary Food
- 3From Overpowered to Coordinated: Individual Accounts of Cleaning up
- 4'Wicked: For Good' was filmed at this surreal National Park in Egypt
- 5Tasting America: An Excursion Through Darling Cheap Food Brands
- Key Little Things That Advantage Old People
- The face is familiar, the name might not be. The king of "Hey, it's that guy!' roles is ready to show you his next act.
- A Gastronomic Experience in Healthy Enjoyments: A Survey of \Nutritious and Tasty\ Solid Cooking Recipe Book
- 5 Movies That Leaving an Imprint with Inventive Innovation
- Rediscovering Imagination in Adulthood: Individual Creative Excursions
- The most effective method to Distinguish the Best Material Organization in Your Space
- Who is Adm. Frank 'Mitch' Bradley and what does he have to do with the Venezuela boat strikes?
- National health ranking puts Georgia near bottom of list. Here's why
- DEA seizes 1.7 million counterfeit fentanyl pills in Colorado storage unit
